Targeted therapies and other agents as first-line maintenance and beyond: particular benefit in pulmonary adenocarcinoma patients.

Source:http://linkedlifedata.com/resource/pubmed/id/21428883

Download in:

View as

Triples

General Info

PMID
21428883